TECX · Tectonic Therapeutic, Inc. · Executive Compensation
$22.54
-0.13 (-0.57%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$462.73M
Shares
19.55M
Volume · Oct 2
253.43K
Avg daily vol (3M)
221.58K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Alise Reicin | President, CEO and Director | $7,351,578 |
| Daniel Lochner | M.B.A. Chief Financial Officer | $3,101,114 |
| Marcella K. Ruddy | Chief Medical Officer | $3,069,630 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Alise Reicin | President, CEO and Director | $5,900,979 |
| Daniel Lochner | M.B.A. Chief Financial Officer | $2,284,007 |
| Marcella K. Ruddy | Chief Medical Officer | $1,840,892 |
| Erik Ostrowski | M.B.A. Former President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $1,093,258 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Erik Ostrowski | M.B.A. Former President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $1,590,892 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Geoff MacKay | Former President and Chief Executive Officer | $2,037,292 |
| Erik Ostrowski | President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $1,352,093 |
| Azadeh Golipour | Chief Technology Officer | $1,026,038 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Geoff MacKay | Former President and Chief Executive Officer | $5,363,022 |
| Christopher Mason | Chief Scientific Officer | $2,736,744 |
| Erik Ostrowski | President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $2,705,607 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Geoff MacKay | President and Chief Executive Officer | $4,904,395 |
| Birgitte Volck | M.D., Ph.D. Former President of R&D | $2,397,398 |
| Erik Ostrowski | Chief Financial Officer and Treasurer | $2,010,017 |
| Steven Avruch | Chief Legal Officer and Secretary | $1,766,976 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Erik Ostrowski | Chief Financial Officer and Treasurer | $2,753,795 |
| Geoff MacKay | President and Chief Executive Officer | $1,816,378 |
| Steven Avruch | Chief Legal Officer and Secretary | $1,384,377 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Geoff MacKay | President and Chief Executive Officer | $2,866,434 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Terrance McGuire | Chair of the Board | Resigned | 2026-02-24 |
| François Nader | Chair of the Board | Appointed | 2026-02-24 |
| François Nader | member of the Board | Appointed | 2026-02-24 |
| Dr. Christian Cortis | Chief Operating Officer | Terminated | 2024-07-05 |
| Marc Schwabish | Chief Business Officer | Appointed | 2024-06-20 |
| Marcella K. Ruddy | Chief Medical Officer | Appointed | 2024-06-20 |
| Peter McNamara | Chief Scientific Officer | Appointed | 2024-06-20 |
| Christian Cortis | Chief Operating Officer | Appointed | 2024-06-20 |
| Azadeh Golipour | all of their offices with AVROBIO and all of its subsidiaries | Resigned | 2024-06-20 |
| Essra Ridha | all of their offices with AVROBIO and all of its subsidiaries | Resigned | 2024-06-20 |
| Alise Reicin | Chief Executive Officer and principal executive officer | Appointed | 2024-06-20 |
| Steven Avruch | all of their offices with AVROBIO and all of its subsidiaries | Resigned | 2024-06-20 |
| Marcella K. Ruddy, M.D. | Chief Medical Officer | Appointed | 2024-06-20 |
| Marc Schwabish, Ph.D. | Chief Business Officer | Appointed | 2024-06-20 |
| Christian Cortis, Ph.D. | Chief Operating Officer | Appointed | 2024-06-20 |
| Daniel Lochner | Chief Financial Officer and principal financial officer and principal accounting officer | Appointed | 2024-06-20 |
| Peter McNamara, Ph.D. | Chief Scientific Officer | Appointed | 2024-06-20 |
| Alise Reicin, M.D. | Chief Executive Officer and principal executive officer | Appointed | 2024-06-20 |
| Erik Ostrowski | President, Interim Chief Executive Officer and Chief Financial Officer (principal executive officer, principal financial officer | Resigned | 2024-06-20 |
| Phillip B. Donenberg | member of the board of directors | Appointed | 2024-06-20 |
| Stefan Vitorovic, M.S., M.B.A. | member of the board of directors | Appointed | 2024-06-20 |
| Praveen Tipirneni, M.D. | member of the board of directors | Appointed | 2024-06-20 |
| Terrance McGuire | member of the board of directors | Appointed | 2024-06-20 |
| Timothy A. Springer, Ph.D. | member of the board of directors | Appointed | 2024-06-20 |
| Bruce Booth, D.Phil. | member of the board of directors | Resigned | 2024-06-20 |